Otc - Active Ingredient
Phellinus linteus mycelium
Messima Ex
FDA Label NDC 53144-2001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Yein Trading & Global Co., Ltd for the product Messima Ex (NDC 53144-2001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
A-Methyl-D(+)-Glucoside
Otc - Purpose
- effective in uterine discharge and bleeding, dysmenorrheal, intestinal bleeding and activation of GI system-improving the immune functions of cancer patients after surgical resection of stomach, colon, or liver
Otc - Keep Out Of Reach Of Children
Keep out of reach of the children
Indications & Usage
- effective in uterine discharge and bleeding, dysmenorrheal, intestinal bleeding, and activation of GI system, 550-1100mg twice a day before meals- effective in improving the immune functions of cancer patients after surgical resection of stomach, colon, or liver, 1100mg three times a day before meals
Warnings
- GI system: may cause nausea, vomiting, diarrhea, or abdominal discomfort- dizziness (one case), headache (one case), and constipation (three cases) were reported during clinical trials
Dosage & Administration
For oral use only
* Please review the disclaimer below.
